John E. Donello

Person

Dana Point, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...
- Patent number 11,331,306
- Issue date May 17, 2022
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
- Patent number 11,208,377
- Issue date Dec 28, 2021
- Allergan, Inc.
- Christopher D. Hein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Sulfur derivatives as chemokine receptor modulators
- Patent number 11,046,644
- Issue date Jun 29, 2021
- Allergan, Inc.
- Haiqing Yuan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amide derivatives of N-urea substituted amino acids as formyl pepti...
- Patent number 10,993,931
- Issue date May 4, 2021
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of agonists of formyl peptide receptor 2 for treating ocular in...
- Patent number 10,899,780
- Issue date Jan 26, 2021
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of agonists of formyl peptide receptor 2 for treating dermatolo...
- Patent number 10,799,518
- Issue date Oct 13, 2020
- Allergan, Inc.
- Veena Viswanath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...
- Patent number 10,555,933
- Issue date Feb 11, 2020
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of agonists of formyl peptide receptor 2 for treating dermatolo...
- Patent number 10,434,112
- Issue date Oct 8, 2019
- Allergan, Inc.
- Veena Viswanath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfur derivatives as chemokine receptor modulators
- Patent number 10,287,243
- Issue date May 14, 2019
- Allergan, Inc.
- Haiqing Yuan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Method of activating regulatory T cells with alpha-2B adrenergic re...
- Patent number 10,251,865
- Issue date Apr 9, 2019
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of agonists of formyl peptide receptor 2 for treating ocular in...
- Patent number 10,208,071
- Issue date Feb 19, 2019
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5...
- Patent number 10,201,535
- Issue date Feb 12, 2019
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amide derivatives of N-urea substituted amino acids as formyl pepti...
- Patent number 10,172,832
- Issue date Jan 8, 2019
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions including encapsulated isotretinoin and methods for us...
- Patent number 10,123,988
- Issue date Nov 13, 2018
- Allergan, Inc.
- John E. Donello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amide derivatives of N-urea substituted amino acids as formyl pepti...
- Patent number 9,974,772
- Issue date May 22, 2018
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors...
- Patent number 9,902,710
- Issue date Feb 27, 2018
- Exonhit Therapeutics, SA
- Bertrand Leblond
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alpha-2 adrenergic agonist having long duration of intraocular pres...
- Patent number 9,889,088
- Issue date Feb 13, 2018
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Carbamoyl hydrazine derivatives as formyl peptide modulators
- Patent number 9,868,700
- Issue date Jan 16, 2018
- Allergan, Inc.
- Vidyasagar Vuligonda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,849,113
- Issue date Dec 26, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of agonists of formyl peptide receptor 2 for treating ocular in...
- Patent number 9,850,264
- Issue date Dec 26, 2017
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-...
- Patent number 9,828,349
- Issue date Nov 28, 2017
- ExonHit Therapeutics S.A.
- Bertrand Leblond
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors...
- Patent number 9,670,181
- Issue date Jun 6, 2017
- Allergan, Inc.
- Bertrand Leblond
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 m...
- Patent number 9,670,150
- Issue date Jun 6, 2017
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine rece...
- Patent number 9,670,190
- Issue date Jun 6, 2017
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbamoyl hydrazine derivatives as formyl peptide modulators
- Patent number 9,663,457
- Issue date May 30, 2017
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfur derivatives as chemokine receptor modulators
- Patent number 9,663,460
- Issue date May 30, 2017
- Allergan, Inc.
- Haiqing Yuan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of inflammatory bowel disease
- Patent number 9,637,467
- Issue date May 2, 2017
- Allergan, Inc.
- Yariv Donde
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating α adrenergic mediated conditions
- Patent number 9,623,006
- Issue date Apr 18, 2017
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1,2- bis-sulfonamide derivatives as chemokine receptor modulators
- Patent number 9,603,834
- Issue date Mar 28, 2017
- Allergan, Inc.
- Haiqing Yuan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Amide derivatives of N-urea substituted amino acids as formyl pepti...
- Patent number 9,579,307
- Issue date Feb 28, 2017
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
- Publication number 20240400501
- Publication date Dec 5, 2024
- Allergan, Inc.
- Christopher D. Hein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...
- Publication number 20240285584
- Publication date Aug 29, 2024
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20230062049
- Publication date Mar 2, 2023
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
- Publication number 20220402866
- Publication date Dec 22, 2022
- Allergan, Inc.
- Christopher D. Hein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...
- Publication number 20220233505
- Publication date Jul 28, 2022
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...
- Publication number 20220202777
- Publication date Jun 30, 2022
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...
- Publication number 20220008393
- Publication date Jan 13, 2022
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...
- Publication number 20210008085
- Publication date Jan 14, 2021
- Allergan, Inc.
- Veena Viswanath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...
- Publication number 20210000846
- Publication date Jan 7, 2021
- Allergan, Inc.
- Veena Viswanath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...
- Publication number 20200390747
- Publication date Dec 17, 2020
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT WITH NMDA RECEPTOR MODULATORS
- Publication number 20200368310
- Publication date Nov 26, 2020
- Naurex, Inc.
- Pradeep Banerjee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20200330428
- Publication date Oct 22, 2020
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...
- Publication number 20200246360
- Publication date Aug 6, 2020
- Allergan, Inc.
- Veena Viswanath
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...
- Publication number 20200206193
- Publication date Jul 2, 2020
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT WITH NMDA RECEPTOR MODULATORS
- Publication number 20200197365
- Publication date Jun 25, 2020
- Naurex Inc.
- Pradeep Banerjee
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROSTACYCLIN RECEPTOR AGONISTS FOR REDUCTION OF BODY FAT
- Publication number 20200171026
- Publication date Jun 4, 2020
- Allergan, Inc.
- Yong-Xin Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
- Publication number 20200109110
- Publication date Apr 9, 2020
- Allergan, Inc.
- Haiqing YUAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...
- Publication number 20190343804
- Publication date Nov 14, 2019
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS, COMPOSITIONS, AND COMPOUNDS FOR TREATMENT OF DERMATOLOGICA...
- Publication number 20190275022
- Publication date Sep 12, 2019
- Allergan, Inc.
- Mohammed DIBAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...
- Publication number 20190240200
- Publication date Aug 8, 2019
- Allergan, Inc.
- Mohammed I. Dibas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS INCLUDING ENCAPSULATED ISOTRETINOIN AND METHODS FOR US...
- Publication number 20190192467
- Publication date Jun 27, 2019
- John E. Donello
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR IN...
- Publication number 20190153004
- Publication date May 23, 2019
- Allergan, Inc.
- Richard L. Beard
- C07 - ORGANIC CHEMISTRY
Information Patent Application
3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF
- Publication number 20190047947
- Publication date Feb 14, 2019
- Allergan, Inc.
- Christopher D. Hein
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180344692
- Publication date Dec 6, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...
- Publication number 20180228772
- Publication date Aug 16, 2018
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RE...
- Publication number 20180071259
- Publication date Mar 15, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS
- Publication number 20180071260
- Publication date Mar 15, 2018
- Allergan, Inc.
- Daniel W. Gil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR IN...
- Publication number 20170320897
- Publication date Nov 9, 2017
- Allergan, Inc.
- Richard L. Beard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...
- Publication number 20170216326
- Publication date Aug 3, 2017
- Allergan, Inc.
- Veena Viswanath
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CARBAMOYL HYDRAZINE DERIVATIVES AS FORMYL PEPTIDE MODULATORS
- Publication number 20170183298
- Publication date Jun 29, 2017
- Allergan, Inc.
- Vidyasagar Vuligonda
- C07 - ORGANIC CHEMISTRY

John E. Donello

Person

Patents Grantslast 30 patents

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...

3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof

Sulfur derivatives as chemokine receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl pepti...

Use of agonists of formyl peptide receptor 2 for treating ocular in...

Use of agonists of formyl peptide receptor 2 for treating dermatolo...

Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)eth...

Use of agonists of formyl peptide receptor 2 for treating dermatolo...

Sulfur derivatives as chemokine receptor modulators

Method of activating regulatory T cells with alpha-2B adrenergic re...

Use of agonists of formyl peptide receptor 2 for treating ocular in...

Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5...

Amide derivatives of N-urea substituted amino acids as formyl pepti...

Compositions including encapsulated isotretinoin and methods for us...

Amide derivatives of N-urea substituted amino acids as formyl pepti...

Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors...

Alpha-2 adrenergic agonist having long duration of intraocular pres...

Carbamoyl hydrazine derivatives as formyl peptide modulators

Methods of treating α adrenergic mediated conditions

Use of agonists of formyl peptide receptor 2 for treating ocular in...

1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-...

Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors...

(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 m...

Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine rece...

Carbamoyl hydrazine derivatives as formyl peptide modulators

Sulfur derivatives as chemokine receptor modulators

Treatment of inflammatory bowel disease

Methods of treating α adrenergic mediated conditions

1,2- bis-sulfonamide derivatives as chemokine receptor modulators

Amide derivatives of N-urea substituted amino acids as formyl pepti...

Patents Applicationslast 30 patents

3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...

PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...

TREATMENT WITH NMDA RECEPTOR MODULATORS

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...

PHARMACEUTICAL COMPOSITIONS COMPRISING (3-(1-(1H-IMIDAZOL-4-YL)ETHY...

TREATMENT WITH NMDA RECEPTOR MODULATORS

PROSTACYCLIN RECEPTOR AGONISTS FOR REDUCTION OF BODY FAT

SULFUR DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...

METHODS, COMPOSITIONS, AND COMPOUNDS FOR TREATMENT OF DERMATOLOGICA...

PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETH...

COMPOSITIONS INCLUDING ENCAPSULATED ISOTRETINOIN AND METHODS FOR US...

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR IN...

3,4-DISUBSTITUTED 3-CYCLOBUTENE-1,2-DIONES AND USE THEREOF

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTI...

METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RE...

METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING OCULAR IN...

USE OF AGONISTS OF FORMYL PEPTIDE RECEPTOR 2 FOR TREATING DERMATOLO...

CARBAMOYL HYDRAZINE DERIVATIVES AS FORMYL PEPTIDE MODULATORS